The table below shows Syndax Pharmaceuticals Inc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$64.86M
$45.87M
$37.96M
$20.04M
$12.50M
$3.50M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$58.84M
$56.28M
$62.23M
$61.64M
$70.97M
$48.66M
SG&A
SNDX annual revenue (10-K history)
Syndax Pharmaceuticals Inc reported annual revenue of $172.35M for fiscal year 2025. That is up 627.8% from $23.68M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.22M (FY 2016) to $172.35M. Figures come from the company's audited annual reports as filed with the SEC.